Enhancing cancer-fighting T cells by manipulating their microenvironment
Genetically engineered T cells have been successful in treating blood cancers but have yielded limited benefits in solid tumors. Scientists have explored different combination strategies to overcome the problem but faced disappointing efficacy or unacceptable side effects.